Science & Research
Texas Functional Health Centers Launches TRUForm Program for Chronic Pain Rehabilitation
Texas Functional Health Centers has introduced a structured 90-day rehabilitation program that addresses chronic pain through neuromuscular re-education and functional movement retraining, offering an alternative for patients who haven't found relief through traditional treatments.
NIH Whistleblower Complaints Highlight Political Interference in Scientific Decision-Making
Two former NIH officials allege retaliation for prioritizing science over politics in vaccine and research grant decisions, raising concerns about political influence on public health institutions.
Clene Inc. Advances Toward NDA Submission for ALS Therapy CNM-Au8®
Clene Inc. is progressing toward submitting a New Drug Application for its ALS treatment CNM-Au8® by late 2025, potentially offering new hope for patients with this devastating neurodegenerative disease.
Soligenix Expands Rare Disease and Public Health Pipeline in Latest Corporate Strategy Update
Soligenix Inc. showcases its dual-focused strategy addressing both rare diseases with unmet medical needs and critical public health threats through its latest corporate presentation, positioning the company as a significant player in specialized therapeutics and biodefense solutions.
VolitionRx Partners with Werfen to Advance Diagnostic Testing for Antiphospholipid Syndrome
VolitionRx has signed an agreement with Werfen to evaluate its Nu.Q NETs assay for improved detection and monitoring of antiphospholipid syndrome, potentially transforming diagnosis and management for millions of patients worldwide.
Gyre Therapeutics Advances Hydronidone Toward China Approval and Expands Clinical Pipeline
Gyre Therapeutics has submitted Hydronidone for approval in China and initiated a U.S. Phase 2 trial, positioning the company for significant growth in liver fibrosis treatment markets.
WHAM Edge Awards 2025 to Fund Early-Career Researchers in Women's Health
The WHAM Edge Awards provide critical $25,000 grants to early-career researchers investigating how biological sex influences health outcomes, addressing systemic funding gaps and economic disparities in women's health research.
OS Therapies Advances Toward 2026 Osteosarcoma Drug Launch with FDA RMAT Designation
OS Therapies Inc. achieves critical regulatory milestones for its OST-HER2 immunotherapy, positioning for potential accelerated approval and U.S. commercial launch in 2026 to address a 40-year treatment gap in osteosarcoma.
D-Wave Quantum Releases Open-Source Toolkit to Accelerate Quantum AI Development
D-Wave Quantum Inc. has launched new open-source tools enabling developers to integrate quantum computing with machine learning frameworks, potentially accelerating practical applications of quantum AI in various industries.
Center for Excellence in Education Fuels STEM Leadership Through Four Decades of Innovation
The Center for Excellence in Education has cultivated STEM talent for over 40 years, producing leaders at top companies and addressing critical global challenges through its innovative programs.
Heart Disease Prevention Strategies Emphasize Diet, Exercise and Stress Management
New recommendations highlight practical steps including consuming heart-healthy foods like grapes, regular exercise, and stress reduction to combat heart disease, the leading cause of death in the United States.
D-Wave Releases Open-Source Quantum AI Toolkit to Accelerate Machine Learning Integration
D-Wave Quantum Inc. has launched an open-source quantum AI toolkit that enables direct integration between quantum computers and PyTorch, representing a significant advancement in making quantum computing more accessible for AI and machine learning applications.
GeoVax's Multi-Antigen COVID-19 Vaccine Shows Promise for Immunocompromised Patients
GeoVax Labs will present clinical data demonstrating that its GEO-CM04S1 vaccine generates cross-variant antibody and robust cellular immune responses in immunocompromised patients with hematologic malignancies, potentially addressing a critical gap in COVID-19 protection for vulnerable populations.
National Survey Reveals Nearly Half of US Adults Experience Unexplained or Treatment-Resistant Pain and Illness
A groundbreaking national survey to be presented at the Association for the Treatment of Neuroplastic Symptoms conference shows that 40% of Americans seeking medical care have symptoms likely caused by stress-induced neural pathway changes rather than structural issues.
Childhood High Blood Pressure Linked to 40-50% Higher Risk of Early Cardiovascular Death
New research reveals that children with elevated blood pressure at age 7 face significantly increased risk of premature cardiovascular death by mid-50s, highlighting the critical importance of early blood pressure monitoring and heart-healthy habits.
New Medication Baxdrostat Shows Promise in Lowering Blood Pressure and Slowing Kidney Disease Progression
The novel medication baxdrostat demonstrated significant reductions in systolic blood pressure and urine albumin levels in patients with chronic kidney disease and uncontrolled hypertension, potentially offering new treatment options for this high-risk population.
2025 World Young Scientist Summit Opens Registration with Focus on Sustainable Development and Innovation
The 2025 World Young Scientist Summit has opened registration and paper submissions, offering young researchers a global platform to address sustainable development goals through technological innovation.
Diesel Engine Pioneer Recognized for 50 Years of Emissions Reduction Breakthroughs
Dave Merrion's career-long research in diesel engine technology achieved a 99.9% reduction in emissions while improving fuel efficiency and engine durability, earning him the John Johnson Medal for Outstanding Research.
NCI Ends 26-Year Funding for Pediatric Brain Cancer Research Consortium
The National Cancer Institute's termination of funding for a long-running pediatric brain cancer research program highlights growing reliance on private sector entities like CNS Pharmaceuticals Inc. to advance critical childhood cancer treatments.
Youth-Created Panther Sculpture Symbolizes Community Partnership for Cancer Research
Four young artists from Boys & Girls Clubs of Broward County created a symbolic panther sculpture that merges art, community, and philanthropy to raise funds for cancer research through the Panthers on the Prowl initiative.
Hypertensive Kidney Disease Deaths Surge 48% Over 25 Years, Revealing Persistent Health Disparities
New research shows a nearly 50% increase in U.S. deaths from high blood pressure-related kidney disease since 1999, with Black individuals experiencing death rates over three times higher than other groups, highlighting urgent need for improved screening and management.
Girl Scouts of Southeast Florida Inspire Future STEM Leaders at STEMapalooza 2025
The Girl Scouts of Southeast Florida hosted STEMapalooza 2025, engaging 250 participants in hands-on STEM activities to inspire career exploration and highlight the importance of early STEM education for youth development.
Soligenix Receives FDA Orphan Drug Designation for Dusquetide in Behçet's Disease Treatment
Soligenix Inc. has secured FDA orphan drug designation for its investigational therapy dusquetide, marking a significant advancement in treating Behçet's disease following promising phase 2a clinical trial results.
Clene's CNM-Au8 Shows Promise in Parkinson's Disease Preclinical Study
Clene Inc. presented preclinical data demonstrating its investigational drug CNM-Au8 improves mitochondrial function and reduces inflammation in Parkinson's disease models, potentially offering a new neuroprotective treatment approach.
CCRM Miami's Integrated Fertility Care Model Addresses Growing Demand in South Florida
CCRM Fertility's Aventura clinic offers comprehensive on-site fertility services with personalized care, reflecting increasing accessibility and scientific advancements in reproductive medicine.
Soligenix Announces Two-Year Stability for Thermostable Ebolavirus Vaccines
Soligenix's ThermoVax platform demonstrates extended vaccine stability at elevated temperatures, potentially revolutionizing global distribution and pandemic preparedness for Ebola and related viruses.
New Research Identifies SOX6 Protein as Potential Key to Myelin Repair in Multiple Sclerosis
Groundbreaking research published in Cell reveals that targeting the SOX6 protein could enable myelin repair in multiple sclerosis patients, potentially opening new therapeutic avenues for the neurodegenerative disease.
Cybin Inc. to Present at H.C. Wainwright Global Investment Conference
Cybin Inc. will present at the H.C. Wainwright 27th Annual Global Investment Conference, highlighting its late-stage neuropsychiatry developments including breakthrough therapy-designated treatments for major depressive disorder and generalized anxiety disorder.
Renaissance BioScience Secures Australian Patent for Revolutionary RNA Production Technology
Renaissance BioScience has obtained an Australian patent for its yeast-based RNA production platform, enabling cost-effective RNA applications in agriculture, animal health, and human medicine with significant market potential.
BRAIN Biotech AG Appoints New Executive Vice President to Lead Enzyme Products Division
BRAIN Biotech AG has appointed Johan Jansen-Storbacka as Executive Vice President of its enzyme products business, signaling a strategic move to strengthen its position in the growing biocatalysts market and enhance integration between research and production capabilities.